Financials of Piramal Pharma Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Piramal Pharma Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +2,163.581,748.851,911.381,958.572,552.361,951.142,241.752,204.222,754.071,933.712,043.722,139.872,751.77
Expenses +1,812.311,616.531,645.741,690.202,022.431,746.651,900.141,866.482,193.081,827.011,885.031,944.142,291.26
Operating Profit351.27132.32265.64268.37529.93204.49341.61337.74560.99106.70158.69195.73460.51
OPM %16.24%7.57%13.90%13.70%20.76%10.48%15.24%15.32%20.37%5.52%7.76%9.15%16.74%
Other Income +32.2852.7068.3043.197.9041.9478.3729.1858.2597.7180.3912.39-116.14
Interest104.25118.52109.87105.88114.22106.96107.64103.31103.6886.1582.4289.2482.99
Depreciation184.41173.61184.51186.32196.13184.55192.22196.81242.76197.28202.84212.74218.38
Profit before tax94.89-107.1139.5619.36227.48-45.08120.1266.80272.80-79.02-46.18-93.8643.00
Tax %47.19%-7.96%87.31%47.78%55.48%96.63%81.19%94.49%43.73%3.39%114.85%45.10%120.53%
Net Profit +50.11-98.585.0210.11101.27-88.6422.593.68153.50-81.70-99.22-136.19-8.83
EPS in Rs0.38-0.750.040.080.77-0.670.170.031.16-0.61-0.75-1.02-0.07

Financials of Piramal Pharma Ltd

Profit & Loss

Annual income statement trend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +6,3156,5597,0828,1719,1518,869
Expenses +4,8875,6096,4536,9747,7067,947
Operating Profit1,4289506291,1971,445922
OPM %23%14%9%15%16%10%
Other Income +23031927217220874
Interest163198344448422341
Depreciation545586677741816831
Profit before tax949485-120179415-176
Tax %12%22%55%90%78%85%
Net Profit +835376-1861891-326
EPS in Rs-1.410.130.69-2.45
Dividend Payout %0%18%0%82%20%0%

Financials of Piramal Pharma Ltd

Balance Sheet

Capital structure and asset base

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9951,1861,1931,3231,3241,327
Reserves4,6105,5115,5806,5886,8016,835
Borrowings +3,0254,1285,6374,7104,8565,675
Other Liabilities +2,0471,7811,8932,4612,4474,128
Total Liabilities10,67712,60514,30315,08315,42917,965
Fixed Assets +6,1056,8797,4697,9908,1338,985
CWIP6271,1721,4191,116977799
Investments123267639385291437
Other Assets +3,8224,2864,7775,5926,0287,744
Total Assets10,67712,60514,30315,08315,42917,965

Financials of Piramal Pharma Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +5987664841,0058921,653
Cash from Investing Activity +-4,464-1,737-1,334-416-488-826
Cash from Financing Activity +3,977794818-422-441-39
Net Cash Flow110-177-32166-37788
Free Cash Flow-5-91-461294233776
CFO/OP52%98%107%97%85%202%

Financials of Piramal Pharma Ltd

Ratios

Working capital efficiency and return ratios

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days919993959489
Inventory Days218207227269261345
Days Payable163153161190173279
Cash Conversion Cycle147153159174182155
Working Capital Days443613216050
ROCE %7%2%5%6%3%